Chinese four-strain flu vaccine to hit market in 2018
Chinese four-strain flu vaccine to hit market in 2018 Source: Xinhua | 2018-02-17 20:29:32 | Editor: Lifang BEIJING, Feb. 17 (Xinhua) -- A vaccine to protect people against four subtypes of seasonal influenza viruses is expected to be available on the Chinese market in the second half of 2018, a health official said. Gao Fu, director of the Chinese Center for Disease Control and Prevention (China CDC), said the upcoming vaccine would be made in China, though other four-strain vaccines have been made available on the European and American markets. There are four common subtypes of seasonal flu viruses: H1N1 and H3N2 of Influenza A, and Victoria and Yamagata lineages of Influenza B. A four-strain vaccine protects against all four and is more effective. But no vaccine can provide a full guarantee, Gao was quoted as saying by the Health News, a newspaper of the National Health and Family Planning Commission. However, taking a shot, which costs a few dozen yuan, makes more economic sense